The SWE modality is useful for qualitative and quantitative assessment of liver injury in patients with Hepatitis B, Hepatitis C, fatty liver and alcoholic liver disease. Shear wave elastography is found to be accurate in quantifying the degree of liver fibrosis and is a invaluable tool for the treatment monitoring of liver diseased patients.
We know that the correct staging of hepatic fibrosis is of critical importance not only for diagnosis, but also for antiviral treatment decision-making.
That’s why MultiWave™ Technology brings you impeccable image quality and non-invasive, real-time, quantitative ShearWave™ Elastography (SWE™) to better image liver disease.
Aixplorer is the first ultrasound system to provide you with the following imaging benefits of ShearWave Elastography: